Papanek Julie Grant

Papanek Julie Grant (board member) discloses dealings in Day One Biopharmaceuticals, Inc. to SEC (Form 4). We count 14 filings; the first trade dates from 1 June 2021 and the latest from 2 September 2022.

On the open market, the record shows 1 purchase worth €170k and 11 sales worth €577k. On balance, insiders were net sellers of €407k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2022, the count stands at no purchases and 11 sales.

On 15 September 2022 came the latest disclosure, an open-market sale for €120k in Day One Biopharmaceuticals, Inc. The clock since the last published purchase (2 June 2021) now reads 1,986 days. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.